DK0630231T3 - Liposomer med negativ overskudsladning - Google Patents

Liposomer med negativ overskudsladning

Info

Publication number
DK0630231T3
DK0630231T3 DK93920536.5T DK93920536T DK0630231T3 DK 0630231 T3 DK0630231 T3 DK 0630231T3 DK 93920536 T DK93920536 T DK 93920536T DK 0630231 T3 DK0630231 T3 DK 0630231T3
Authority
DK
Denmark
Prior art keywords
liposomes
pct
mol
excess charge
sec
Prior art date
Application number
DK93920536.5T
Other languages
Danish (da)
English (en)
Inventor
Clemens Unger
Hansjoerg Eibl
Petra Kaufmann-Kolle
Anneliese Kranich
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK0630231T3 publication Critical patent/DK0630231T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK93920536.5T 1992-03-17 1993-03-16 Liposomer med negativ overskudsladning DK0630231T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4208527A DE4208527A1 (de) 1992-03-17 1992-03-17 Liposomen mit negativer ueberschussladung

Publications (1)

Publication Number Publication Date
DK0630231T3 true DK0630231T3 (da) 1996-07-22

Family

ID=6454285

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93920536.5T DK0630231T3 (da) 1992-03-17 1993-03-16 Liposomer med negativ overskudsladning

Country Status (14)

Country Link
US (1) US5626867A (pt)
EP (1) EP0630231B1 (pt)
JP (1) JPH07507542A (pt)
KR (1) KR100243933B1 (pt)
AT (1) ATE134872T1 (pt)
AU (1) AU672600B2 (pt)
BR (1) BR9306117A (pt)
CA (1) CA2132347C (pt)
DE (2) DE4208527A1 (pt)
DK (1) DK0630231T3 (pt)
ES (1) ES2085793T3 (pt)
GR (1) GR3019546T3 (pt)
NZ (1) NZ249852A (pt)
WO (1) WO1993018749A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
CZ290029B6 (cs) * 1993-10-06 2002-05-15 Amgen Inc. Fosfolipid-proteinový přípravek
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US8853260B2 (en) * 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
AU1350099A (en) * 1997-12-01 1999-06-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Formulations for topical treatment of skin infections
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
US9364569B2 (en) 2003-02-04 2016-06-14 Bracco Suisse S.A. Ultrasound contrast agents and process for the preparation thereof
CA2547024C (en) * 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
CA2575677C (en) 2004-08-18 2013-01-22 Bracco Research Sa Gas-filled microvesicles composition for contrast imaging
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity
TWI438009B (zh) * 2010-02-19 2014-05-21 Teikoku Pharma Usa Inc 紫杉烷前－乳劑調配物及其製造與使用之方法
CA2798180A1 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102324C (pt) *
US4186183A (en) * 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4917897A (en) * 1982-01-22 1990-04-17 Fisons Plc Pharmaceutical compositions
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden
EP0102324A3 (de) * 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
EP0113508A1 (en) * 1982-11-04 1984-07-18 Inco Research & Development Center, Inc. Hydrophobic platinum compounds and their preparation
US5387410A (en) * 1983-03-18 1995-02-07 Mallinckrodt, Inc. Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
US5169637A (en) * 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
DE3328667A1 (de) * 1983-08-09 1985-02-21 Bomoro Bocklenberg & Motte Gmbh & Co Kg, 5600 Wuppertal Kraftfahrzeug-tuerschloss, -haubenschloss od. dgl. mit motorischer schliesshilfe
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
WO1988006437A1 (en) * 1987-02-27 1988-09-07 Terumo Kabushiki Kaisha Process for preparing liposome
US4828837A (en) * 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
US4938965A (en) * 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
WO1989008499A1 (en) * 1988-03-17 1989-09-21 Nippon Fine Chemical Co., Ltd. Liposome
DE3825374A1 (de) * 1988-07-26 1990-02-01 Schwendener Reto Dipl Apotheke Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
DE4013632A1 (de) * 1990-04-27 1991-10-31 Max Planck Gesellschaft Liposomen mit positiver ueberschussladung

Also Published As

Publication number Publication date
KR100243933B1 (ko) 2000-03-02
AU672600B2 (en) 1996-10-10
CA2132347C (en) 1999-02-02
BR9306117A (pt) 1998-01-13
ATE134872T1 (de) 1996-03-15
DE59301805D1 (de) 1996-04-11
EP0630231B1 (de) 1996-03-06
ES2085793T3 (es) 1996-06-01
DE4208527A1 (de) 1993-09-23
WO1993018749A1 (de) 1993-09-30
JPH07507542A (ja) 1995-08-24
GR3019546T3 (en) 1996-07-31
EP0630231A1 (de) 1994-12-28
US5626867A (en) 1997-05-06
NZ249852A (en) 1995-11-27
AU3748793A (en) 1993-10-21
CA2132347A1 (en) 1994-09-17

Similar Documents

Publication Publication Date Title
ATE25251T1 (de) Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
DK0630231T3 (da) Liposomer med negativ overskudsladning
SE8002635L (sv) Piperidinderivat
DE3070912D1 (en) Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them
ES8103735A1 (es) Procedimiento para la preparacion de derivados de pipreridi-na
KR960701881A (ko) 나프탈렌포스폰산의 우레이도 유도체 및 이의 제조 방법(Ureido derivatives of naphtha1enephosphonic acids and process for their preparation)
KR840004070A (ko) 2-아자스피로[4(3+m)]-3-카복실산 유도체의 제조방법
AU548974B2 (en) Oligoglucoside derivatives
KR850004472A (ko) 4h-3,i-벤즈옥사진-4-온 유도체의 제조방법
ES8307239A1 (es) Procedimiento para la preparacion de acidos (2-oxo-3-tetrahidrotienilcarbamoil)-alquiltio aceticos.
ES8200123A1 (es) Un procedimiento para la produccion de un ester de coleste- rol
ATE28187T1 (de) Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung.
KR930703336A (ko) 신규한 메틸렌비스포스폰산 유도체
ATE165337T1 (de) Verfahren zur herstellung von festen esterquats
KR840005733A (ko) 무라밀 펩타이드의 제조방법
EP0450527A3 (en) N-tris(hydroxymethyl)methylfatty acid amides and cosmetic compositions containing same
ES8105319A1 (es) Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas
ES8100304A1 (es) Un procedimiento para preparar derivados de indol policiclicos
KR950702566A (ko) 사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds)
ES8404325A1 (es) "procedimiento de obtencion de acidos alfa-n-pirrolil-derivados".
DE3462400D1 (en) Carboxylic acid derivatives, processes for their production and pharmaceutical preparations containing them
ATE29251T1 (de) Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR850008333A (ko) 4-아실레저시놀 에테르의 제조방법
EP0653206A4 (en) ANTI-HIV ACTIVE SUBSTANCE.
KR960701832A (ko) Ng-모노알킬-l-아르기닌 및 관련 화합물의 제조 방법(process for preparing ng-monoalkyl-l-arginine and related compounds)